CollPlant Biotechnologies (CLGN) Earnings Date & Reports
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics... Show more
CLGN is expected to report earnings to rise 16.57% to -24 cents per share on August 20
Q2'26
Est.
$-0.24
Q1'26
Beat
by $0.03
Q4'25
Missed
by $0.13
Q3'25
Missed
by $0.41
Q2'25
Beat
by $0.37
The last earnings report on May 29 showed earnings per share of -20 cents, beating the estimate of -23 cents. With 44.45K shares outstanding, the current market capitalization sits at 5.34M.